Logo 13 (Oxybutynin Chloride Extended-Release 5 mg)
Pill with imprint Logo 13 is Pink, Round and has been identified as Oxybutynin Chloride Extended-Release 5 mg. It is supplied by Advagen Pharma Limited.
Oxybutynin is used in the treatment of urinary frequency; urinary incontinence; neurogenic detrusor overactivity; dysuria and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo 13
Oxybutynin Chloride Extended-Release
- Imprint
- Logo 13
- Strength
- 5 mg
- Color
- Pink
- Shape
- Round
- Availability
- Rx and/or OTC
- Drug Class
- Urinary antispasmodics
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Advagen Pharma Limited
- Manufacturer
- Rubicon Research Private Limited
- National Drug Code (NDC)
- 72888-0030
Related images for "Logo 13"
More about oxybutynin
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (411)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- Drug class: urinary antispasmodics
Patient resources
- Drug Information
- Oxybutynin transdermal
- Oxybutynin Transdermal (Advanced Reading)
- Oxybutynin Extended-Release Tablets
- Oxybutynin Tablets
Other brands
Ditropan, Ditropan XL, Oxytrol, Gelnique, Anturol
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.